Vivani Medical Net Income Over Time
| VANI Stock | USD 1.26 0.03 2.33% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Vivani Medical Performance and Vivani Medical Correlation. Is there potential for Biotechnology market expansion? Will Vivani introduce new products? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Vivani Medical requires distinguishing between market price and book value, where the latter reflects Vivani's accounting equity. The concept of intrinsic value - what Vivani Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Vivani Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Vivani Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Net Income Analysis
Compare Vivani Medical and related stocks such as InspireMD, Hyperfine, and Avita Medical Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NSPR | (3.8 K) | (17.6 M) | (17.6 M) | (29.3 M) | (25.1 M) | (15.6 M) | (8.5 M) | (8.4 M) | (7.2 M) | (10 M) | (10.5 M) | (14.9 M) | (18.5 M) | (19.9 M) | (32 M) | (28.8 M) | (27.4 M) |
| HYPR | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (23.4 M) | (64.8 M) | (73.2 M) | (44.2 M) | (40.7 M) | (36.6 M) | (38.5 M) |
| RCEL | (225.5 K) | (7.6 M) | (8.1 M) | (5.1 M) | (7.9 M) | (10.3 M) | (11.5 M) | (17.2 M) | (24.6 M) | (24.6 M) | (24.6 M) | (25.1 M) | (26.7 M) | (35.4 M) | (61.8 M) | (55.7 M) | (52.9 M) |
| MBOT | (6.4 M) | (21.3 M) | (28.5 M) | (26.4 M) | (32.7 M) | (36.4 M) | (9.7 M) | (7.6 M) | (7.3 M) | (7.2 M) | (9.2 M) | (11.3 M) | (13.2 M) | (10.7 M) | (11.4 M) | (10.3 M) | (10.8 M) |
| QIPT | (34.1 K) | (548 K) | (2.5 M) | (1.4 M) | (18.3 M) | (57.4 M) | (19.2 M) | 14.5 M | (5.6 M) | (4.6 M) | (6.2 M) | 4.8 M | (2.8 M) | (6.8 M) | (10.7 M) | (9.6 M) | (9.1 M) |
| FONR | (7.5 M) | 5.8 M | 8.7 M | 10.4 M | 12.9 M | 15.7 M | 19.6 M | 21.2 M | 15.3 M | 8.2 M | 10.2 M | 12.4 M | 9.4 M | 10.6 M | 8.3 M | 9.6 M | 10.1 M |
| EDAP | 181.8 K | (938 K) | (7.5 M) | (5 M) | (512 K) | (1.7 M) | 3.8 M | (681 K) | (338 K) | 1.5 M | (1.7 M) | 700 K | (2.9 M) | (21.2 M) | (19 M) | (17.1 M) | (16.3 M) |
| ORMP | (50 K) | (1.6 M) | (3.3 M) | (4.2 M) | (5.7 M) | (7.2 M) | (11 M) | (10.5 M) | (12.7 M) | (14.4 M) | (11.5 M) | (22.2 M) | (37.8 M) | 5.5 M | (19.1 M) | (17.2 M) | (16.3 M) |
| CRDL | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (15.9 M) | (10.6 M) | (16.2 M) | (25 M) | (22.8 M) | (21.2 M) | (36.7 M) | (33 M) | (31.4 M) |
| IMA | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (16.8 M) | (44.3 M) | (34.1 M) | (68.8 M) | (68.2 M) | (36.6 M) | (32.9 M) | (34.6 M) |
Vivani Medical and related stocks such as InspireMD, Hyperfine, and Avita Medical Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Vivani Medical financial statement analysis. It represents the amount of money remaining after all of Vivani Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
Check out Vivani Medical Performance and Vivani Medical Correlation. For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Vivani Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.